Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03946878
Brief Title: Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

First Submitted : May 9, 2019
First Submitted that Met QC Criteria : May 9, 2019
First Posted : May 13, 2019

Last Update Submitted that Met QC Criteria : August 20, 2019
Last Update Posted : August 22, 2019